Received Nov 11, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPAB | HEP A + HEP B (TWINRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
patient received the first dose of Twinrix on 11-19-2024 and never got the second and third dose.; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 56-year-old male patient who received HAB (Twinrix) for prophylaxis. Previously administered products included Twinrix (received 1st dose on 19-NOV-2024). On an unknown date, the patient did not receive the 2nd dose of Twinrix. The patient experienced incomplete course of vaccination (Verbatim: patient received the first dose of Twinrix on 11-19-2024 and never got the second and third dose.). The outcome of the incomplete course of vaccination was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 07-NOV-2025 The pharmacist mentioned that a patient received the first dose of Twinrix on 19th November 2024 and never got the second and third dose. The healthcare professional asked if the series should be re initiated and what would be the interval between doses. No further details provided. The batch number was not provided and a request for this information has been made.